Accessed 20 Apr 2017 Stanley CA, Bennett MJ, Longo N (2014) Plasma membrane carnitine transporter defect, In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G (eds) The online metabolic and molecular bases of inherited disease New York, McGraw-Hill, New York
[...] Table 1 IC50 Values of HDAC Inhibitors that Increase Memory Formation in APPswe/PS1dE9 Mutant Mice [...] al
Yoshimi, A
Thats the mechanism of action in plain English, and its why naltrexone bupropion contrave for weight loss has become such a clinically relevant option
People are excited about it because its a triple agonist, says Jyotsna Ghosh, M.D., an obesity medicine physician at Johns Hopkins Medicine